Evi-2, a common integration site involved in murine myeloid leukemogenesis.

AUTOR(ES)

Buchberg, A M

RESUMO

BXH-2 mice have the highest incidence of spontaneous retrovirally induced myeloid leukemia of any known inbred strain and, as such, represent a valuable model system for identifying cellular proto-oncogenes involved in myeloid disease. Chronic murine leukemia viruses often induce disease by insertional activation or mutation of cellular proto-oncogenes. These loci are identified as common viral integration sites in tumor DNAs. Here we report on the characterization of a novel common viral integration site in BXH-2 myeloid leukemias, designated Evi-2. Within the cluster of viral integration sites that define Evi-2, we identified a gene that has the potential for encoding a novel protein of 223 amino acids. This putative proto-oncogene possesses all of the structural features of a transmembrane protein. Within the transmembrane domain is a "leucine zipper," suggesting that Evi-2 is involved in either homopolymer or heteropolymer formation, which may play an important role in the normal functioning of Evi-2. Interestingly, the human homolog of Evi-2 has recently been shown to be tightly linked to the von Recklinghausen neurofibromatosis locus, suggesting a role for Evi-2 in human disease as well.

Documentos Relacionados

• Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors.
• Activation of cMGF expression is a critical step in avian myeloid leukemogenesis.
• Replication factor encoded by a putative oncogene, set, associated with myeloid leukemogenesis.
• Identification of Evi-3, a novel common site of retroviral integration in mouse AKXD B-cell lymphomas.
• Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis.